logo
Plus   Neg
Share
Email

Catalyst Pharma Inks Deal With Endo For Vigabatrin Tablets

Catalyst Pharmaceuticals Inc. (CPRX), Tuesay said it has inked a deal with Endo International plc's (ENDP) subsidiary, Endo Ventures Limited, for the further development and commercialization of generic Sabril (vigabatrin) tablets through Endo's U.S. Generic Pharmaceuticals segment.

Pursuant to the agreement, Catalyst will receive an up-front payment, milestone payments based on achievement of regulatory approvals, and a sharing of defined net profits upon commercialization.

Catalysts Pharmaceuticals is a biopharmaceutical company focused on developing and commercializing innovative therapies for people with rare debilitating, chronic neuromuscular and neurological diseases.

"We are very happy to work with Endo, to bring generic Sabril® tablets to market. Endo is an established leader in the generic vigabatrin marketplace," said Patrick J. McEnany, Chairman and Chief Executive Officer of Catalyst Pharmaceuticals. "Our search for an appropriate partner for this product was long but rewarding with this result. We look forward to bringing to market this important medication to improve the lives of patients."

"Generic vigabatrin tablets will complement our current powder vigabatrin offering and will expand the number of patients that can benefit from having access to a high-quality, generic vigabatrin option," said Brandon Rockwell, Senior Vice President, Business Development and Strategy of Endo.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Startups Airbnb Inc. and DoorDash Inc. are planning for higher-than-expected valuation ranges for their initial public offerings, the Wall Street Journal reported citing people familiar with the matter. San Francisco-based home rental platform Airbnb is planning to target a range of around $30 billion to $33 billion, higher than the $30 billion it had been expected earlier. U.S. auto safety regulator has opened an investigation into about 115,000 Tesla electric vehicles over a front suspension safety issue. The probe covers 2015 through 2017 Model S sedans and 2016 through 2017 Model X SUVs. The investigation comes after Tesla reportedly started a recall over the issue for vehicles in China. Santa Cruz Bicycles LLC has recalled certain model year 2020 bicycles with aluminum frames citing fall risks, according to the U.S. Consumer Product Safety Commission. The recall involves about 2,900 units of model year 2020 Auminum Santa Cruz and Juliana Bicycles. In addition, about 216 were sold in Canada.
Follow RTT